The University of British Columbia
UBC - A Place of Mind
The University of British Columbia
Faculty of Medicine
  • Home
  • Admissions
  • About
    • Strategic Plan
    • Vision & Values
    • Land Acknowledgement
    • Indigenous Health
    • Leadership
    • Academic & Research Units
    • Campuses
    • Facts & Figures
    • Careers
    • Contact
  • News
    • Feature Stories
    • Pathways Magazine
    • The Next Big Question
  • Education
    • Programs
    • Faculty Development
    • Health Education Scholarship
    • Continuing Professional Development
  • Research
    • Priority Areas
    • Canada’s Immuno-Engineering and Biomanufacturing Hub
    • COVID-19 Clinical Research Coordination Initiative
    • Academy of Translational Medicine
    • Edwin S.H. Leong Centre for Healthy Aging
    • Centres & Institutes
    • National Prizes
  • Giving
    • Impact of Giving
    • By the Numbers
    • Ways to Give
    • Webinar Series
    • Contact Us
  • Prospective Students
  • Current Learners
    • Policies & Procedures
    • Respectful Environments, Equity, Diversity & Inclusion
    • Mistreatment Help
    • MD & Undergrad Research
    • Summer Student Research Program
    • Multidisciplinary Research Program in Medicine
    • Grad & Postdoc Education
  • Faculty & Staff
  • Clinical Faculty
    • Becoming Clinical Faculty
    • Appointment Policy & Compensation Terms
    • Teaching Tracking & Payment System
    • Services & Perks
    • Career Development
    • Awards
    • Celebrating Clinical Faculty
    • Advisory Council
    • Contacts
  • Alumni
» Home » Research in Focus » Carles Vilariño-Güell, Medical Genetics

Carles Vilariño-Güell, Medical Genetics

By Patricia Angel | February 25, 2014

Canada Research Chair in Molecular Characterization of Neurological Diseases

Vilarino-Guell CarlesCarles Vilariño-Güell, an Assistant Professor in the Department of Medical Genetics, uses next-generation sequencing technologies to identify the genetic causes of multiple sclerosis, a disease for which there is no cure. His research will build on a Canada-wide effort spanning over 20 years to obtain thousands of biological samples and detailed clinical information from MS patients and their families. This amazing resource combined with technological advances is allowing the identification of the molecular components implicated in onset and progression of this disease. He expects his team’s research will unravel the molecular etiology of MS, and lead to the development of more efficacious drugs that will provide symptomatic benefit by halting the onset of disease and its progression.

Faculty of Medicine
317 - 2194 Health Sciences Mall
Vancouver, BC Canada V6T 1Z3
Tel 604 822 2421
Website www.med.ubc.ca
Find us on
    
Back to top
The University of British Columbia
  • Emergency Procedures |
  • Terms of Use |
  • Copyright |
  • Accessibility